Robert Hromas
Hematology/Oncology
Biochemistry/Molecular Biology
and the Walther Oncology Center
Indiana University Medical Center
USA
Name/email consistency: high
- The chemokine CCL21 protects normal marrow progenitors from Ara-C cytotoxicity. Hromas, R., Cooper, S., Broxmeyer, H.E. Cancer Chemother. Pharmacol. (2002)
- The exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors. Hromas, R., Cripe, L., Hangoc, G., Cooper, S., Broxmeyer, H.E. Blood (2000)
- A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Hromas, R., Shopnick, R., Jumean, H.G., Bowers, C., Varella-Garcia, M., Richkind, K. Blood (2000)
- Isolation of ALP, a novel divergent murine CC chemokine with a unique carboxy terminal extension. Hromas, R., Broxmeyer, H.E., Kim, C., Christopherson, K., Hou, Y.H. Biochem. Biophys. Res. Commun. (1999)
- Genesis, a Winged Helix transcriptional repressor, has embryonic expression limited to the neural crest, and stimulates proliferation in vitro in a neural development model. Hromas, R., Ye, H., Spinella, M., Dmitrovsky, E., Xu, D., Costa, R.H. Cell Tissue Res. (1999)